Published by Josh White on 18th August 2025
(Sharecast News) - Faron Pharmaceuticals said on Monday that it has secured a clear regulatory pathway for the potential approval of its lead cancer therapy bexmarilimab, following positive feedback from the US Food and Drug Administration.
URL: http://www.digitallook.com/dl/news/story/35293080/...